ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000373.1|Holomycin_1 # 1 # 228 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000373.1|Holomycin_1 	1	228	+	Loose	500	21.9422	FEZ-1	37.04	3000606	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	FEZ beta-lactamase	ATGGTCCGGCGGATCCCCGGTTTCGTGAACCGGGGATCCGCGGCTACCGTGCGCCGCCTCAGCTTCGCCATCACGGTGGCCGCGATGTTCACGGGGTGCTACAAGTTCCGCGGGCGCAGCTACTTCCTCCAGCAGACCGTCGACGCCTTCGAGGAAGAGGCCAACGCCGTCCGGCTCGGCATCGGCCCGTGCAGCGAGTACGGGCCCGCCTGGAGGACGAGGTGCTGA	MVRRIPGFVNRGSAATVRRLSFAITVAAMFTGCYKFRGRSYFLQQTVDAFEEEANAVRLGIGPCSEYGPAWRTRC	MKKVLSLTALMMVLNHSSFAYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFKFSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFTQSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPGYKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLQKGQNNPFVDPTGCKNYIEQKANDFYTELKKQETA	26.60	gnl|BL_ORD_ID|300|hsp_num:0	322			387	468	
BGC0000373.1|Holomycin_2 # 839 # 1693 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0000373.1|Holomycin_2 	839	1693	-	Loose	260	28.1054	FosD	32.0	3004674	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAATTCCCACGACGCGTTCACCGTTTCCACCGCCACCCTGGAGGACTGGTACCAGGTGGCGGAATGGGCGGACGGGGAGGGCTGGAACGTCGGCGACGGCGACGTGGCCTGCTTCCACCCGACCGACCCCGCAGGCTTCTTCATCGGCCGCCTCGGCGCACGTCCCGTCGCGGCCGTCTCCATCGTCAACTACGACGACCGGTACGCCGTCCTCGGCCACTACCTCACCGACCCGGAGTTCCGCGGCCGGGGCTACGGCCTGGCGACCTGGAAGGCGGCCTTCCCGCACTCCGGGAACCGCACGGTCGGCCTGGACGCGATGCCCGCACAGCGAGCCAACTACGAGACGCACGGGTTCAAGGCGGCGCACGACACCGTGCACTTCGCCGGGAGCCCCGCCCGGCCCACCGGGCCCGTACAGGGGGTCGCCCCGGTCACTCCCGAGCACGCCGAGGCCCTGGCCGCCTACGACCGTGGCTGCTTCCCGGCCGACCGGAGCGGGTTCGTCGGCCGATGGCTCACCGCGCCGGGCCGGACCGCCCGCGTCCGGTTGCGCGACGGAGCCGTCGCCGGGTACGGAGTGATCCGTCCGGCCGGTCGCGGGCACCGCATCGGACCGCTCTTCGCGGACACCCCTGAGGACGCCGCCGCGTTGTTCGACGGCCTGGTGGGCCACTTCGGCCCCGGCGAGGAGGTGTCCCTCGACATCCCTGGCACCCACGCCGCTTCGGCGGACCTGCTGACGTCCCGGGGCCTGGCGGCGCAGTTCCACACGGTGCGCATGTACACCGGCCCCGTACCCGAGACCGCCGAAGAGCGGGTCTTCGCCATCACCACTCTCGAACTGGGCTGA	MNSHDAFTVSTATLEDWYQVAEWADGEGWNVGDGDVACFHPTDPAGFFIGRLGARPVAAVSIVNYDDRYAVLGHYLTDPEFRGRGYGLATWKAAFPHSGNRTVGLDAMPAQRANYETHGFKAAHDTVHFAGSPARPTGPVQGVAPVTPEHAEALAAYDRGCFPADRSGFVGRWLTAPGRTARVRLRDGAVAGYGVIRPAGRGHRIGPLFADTPEDAAALFDGLVGHFGPGEEVSLDIPGTHAASADLLTSRGLAAQFHTVRMYTGPVPETAEERVFAITTLELG	MIQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQYSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTLENRLNYYKETKPHMVFYK	204.32	gnl|BL_ORD_ID|2251|hsp_num:0	3373			192	333	fosfomycin
BGC0000373.1|Holomycin_4 # 2912 # 3715 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000373.1|Holomycin_4 	2912	3715	-	Loose	500	25.7942	vph	30.43	3003061	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	viomycin phosphotransferase	ATGAGCCGCGCGACACCCCCGAAGACCCCGGTCCGGCTCTACTGTTTTCCGCACGCCGGCGCCAGTTCCCTGGTGTACCGGGGCTGGCGGGCACCCCAGGGCGTGCCCTTGGAGATCGTCGGCGTCGATCAGCCGGGACGCGGTCCCCGGGCCCGGGACGCCCGCGTCACCCATTACCCGGAGCTGGTCGCCGCCATGGCCGACCAGGTGGCGGCCGATCTGCGGGCGGCCCGCGCGGAGCGGCCCGGGCTGCGCTGGGCCTCCTTCGGCCACAGCTTCGGTGCGACGCTCAGTCTGTCGGTGGCCGCGACGGTCGCGCGGAGACTCGGCGAGCGCCCCGAGCGGTCCGTGCTCTCGGCGGCGCTGCCTCCCCGGCTCCAGCCCGAGACCGTCATCGGCGACCTCGACGACGAAGCGCTGCTGGCCAAGATGGTCGCCGACGGCGGCACCGCCTCCGCGCTGCTGTCCAACACCACGATGACGCGGCTCCTGGTCCGGATGATGCGGGAGGACGAGGAGATCCGCTGTCAGTTCGGCCGGGAGGCGTCCACGCTGCGCGTCGACCACCCGCTGGTCCTGCTCGCCGCACGGGACGACCTCCATGTGACACCCGCCCAGATGGCCGGCTGGGCGGAGCACAGCACCGCACCCAGTCACCGCGTCGAGATCCCCGGTGGCCACTTCGCGGCGGTACTCCAACCCGAGCGGGCTCTCGCTCTGGCAGTCGACGGCACGGCCCGGGCCCCCGAAGGGCGACCGGGCCGGGAAGGGGAATCGCTGACATGCGTGAGCGGCCCGAGGTGA	MSRATPPKTPVRLYCFPHAGASSLVYRGWRAPQGVPLEIVGVDQPGRGPRARDARVTHYPELVAAMADQVAADLRAARAERPGLRWASFGHSFGATLSLSVAATVARRLGERPERSVLSAALPPRLQPETVIGDLDDEALLAKMVADGGTASALLSNTTMTRLLVRMMREDEEIRCQFGREASTLRVDHPLVLLAARDDLHVTPAQMAGWAEHSTAPSHRVEIPGGHFAAVLQPERALALAVDGTARAPEGRPGREGESLTCVSGPR	MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	93.03	gnl|BL_ORD_ID|1200|hsp_num:0	1223			288	603	viomycin
BGC0000373.1|Holomycin_5 # 3712 # 5385 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.738	BGC0000373.1|Holomycin_5 	3712	5385	-	Loose	1150	26.9498	tetB(46)	29.07	3004033	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGCGGAACGGCGCACGGCCTCACGGACGCCACCGGCGGCATCCTCTGGGACCACCTGGTGGTCGGTGCGGGCTCCGCGGGATCGGTCACCGCCGCCCGCCTGGTCTCCGCCGGGGCACGCGTGCTGCTGGTGGAGGCGGGCGGGGAGCAGCCGGAAGGCGGCGCGGAGACCAACCCCCTCCGGGACGCCAACCGCCTCATCCTGGAAGGCTTCAACTGGGACCACCGGGCCAACCTCCGCTCCAGCACCCGGTGGGACGAACTCGTGGGCGTCGGCGGCGCGTCCGGATCCACCGCCGACGCGGGGCGCAGCCGTGCCCTGTGGACCCGCTTCCCCTACCAGCTGGGCAAGGTCGTCGGCGGCTCGTCCGCGGTGAACGGGGCGATCGCGATGCGCCCGCTGCGCAGGGACTTCGACACCTGGGTGGCGCGCGGCAACCCCGACTGGAGCTGGGACCAGGTCCTGCCGTACTACCGCCGGATCGAGAACGACGCGGACCACCCCGGCGACGCGGCGCACGGCGACCACGGAGCGATACCCGTCCGCCGGCCCGGCCCCGCCGACCTGCACGAGCTGGAGGTCGCGTTCCGTGCCGCGTGTCTGCGGATGGGCGTCGAGGACCTGCCCGACCTGAACGGCGGCGGCGAGCGCGGAGTCGGCCCGGTGCCGGCCAACTCCGTCGACGGCGAGCGCGTCGACGCGGCGACCGCCTACCTCACCGACGTACGCAAACTGCCCGAACTGGAGCTGCGCACCGGCTGCCGGGTGACCCGGGTGCTCTTCGAGGGGCGGCGCGCCGTCGGCGCGGTCCTGGTGGACGACGACGGCCACCGCACCGCGGTGCGGGCCCGGAACGTGATCCTGTGCGCGGGCGCGGTCGGCACACCGGTCGTCCTCCAGCGGTCCGGCGTCGGCGATGCCCGGCTGGCGGCCGCCCTCGGTGTGCCCGTCGTCGCCGACCTGCCCGGGGTGGGCGAGAACCTCGCGGACCACCCCTCGGTGGTCATCTGGTCCCTGCCCGGGCCGGGGGTGTGCAAGCCCGGCATGCCGTGGCGGCAGATCGCGGCGCGGATGTCCAGCGGTTACGACGACGACGTCGACGTCCAAGTGGGGCTCCTCAACAACGTGGAGTCCACGACGATCCCCGGGTTCGTCGACCGCCTCGGCTCGCCGATGGCGGTGGGCCTGTCGGTCATGCTGATGCGCCCGGAGTCGCGGGGCCGGGTCTTCGCCGAGAGCGCCGACCCGGACACCCCGCCCGTGATCGAGCTGGGCATGGGCACGGTCGAGCGGGACGTGGAGCGCCTCATGCACGGCGTGCGCAAGGCCTGGGGCATCCTGCGGGCGCCCGGCATCGCCGAGCGCCTGGAGCGGACGCAGTTCTGGACCGACCGGATGATCGGCAACGAGGCCGTGCTGCGCAACGGGGTGCGCAACATCATGAACCCCGGCTGGCACGCGGTCGGTTCGGCCCGCATGGGGCCGCCGTCGGACCGGATGTCCGTGGTCGACCAGCGCGGCCGGGTGCACGGCCTCGAAGGGCTGCGCGTGGTCGACGCCTCCGTCTTCCCCTCGGTGCCGAGCGTCCCCACCAACCTGACCACGCTGATGCTCGCCGAACGCATCGGTGACGACATCGTCGCCGCGTTCAAGGAAGGAGCACCGGCATGA	MSGTAHGLTDATGGILWDHLVVGAGSAGSVTAARLVSAGARVLLVEAGGEQPEGGAETNPLRDANRLILEGFNWDHRANLRSSTRWDELVGVGGASGSTADAGRSRALWTRFPYQLGKVVGGSSAVNGAIAMRPLRRDFDTWVARGNPDWSWDQVLPYYRRIENDADHPGDAAHGDHGAIPVRRPGPADLHELEVAFRAACLRMGVEDLPDLNGGGERGVGPVPANSVDGERVDAATAYLTDVRKLPELELRTGCRVTRVLFEGRRAVGAVLVDDDGHRTAVRARNVILCAGAVGTPVVLQRSGVGDARLAAALGVPVVADLPGVGENLADHPSVVIWSLPGPGVCKPGMPWRQIAARMSSGYDDDVDVQVGLLNNVESTTIPGFVDRLGSPMAVGLSVMLMRPESRGRVFAESADPDTPPVIELGMGTVERDVERLMHGVRKAWGILRAPGIAERLERTQFWTDRMIGNEAVLRNGVRNIMNPGWHAVGSARMGPPSDRMSVVDQRGRVHGLEGLRVVDASVFPSVPSVPTNLTTLMLAERIGDDIVAAFKEGAPA	MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE	96.37	gnl|BL_ORD_ID|2309|hsp_num:0	2644			474	720	tetracycline
BGC0000373.1|Holomycin_6 # 5382 # 8648 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000373.1|Holomycin_6 	5382	8648	-	Loose	1000	144.821	almE	31.51	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGAAGACCTTGTTGCCGAGTCGCTGAACAGTCACCCGCAGACCCTGCCCGGGGCCGAATCGCGCCCTGCGGAACGTCATGACGCGTTCCCGCTGACCGATATCCAGCACGGATACCTGATCGGCCGCCACAAGGGCCTGGAGCTCGGCGGTGTGTCCAGCCACTACTTCTTCGAGTTCGACGGGCCTGCCCTGGACGTCCCCCGCCTCACCACCGCCCTCGGCCGGGTCGTGGAACGCCACGACATGCTCCGTGCGGTGACCGACGCCGACGGAGCCCAGCGGGTCCTGGCCGAGACGCCCCCGTACGCCATCGCCGTCACCGACCTGCGCGAGGTGTCCGATGCCGAACGGGACGAGGCGCTGGCACGCATCCGCGCCGAGCTGGAGAACCAGGTCCTGCCCAGCGACCGTTGGCCGCCCTTCGACATCCGGGCCACGCACCTCCCCGACCGGCGCACCCGGCTGCACGTCAGCGTCGACCTGCTCTTCGTCGACGTCCGCAGCCTCCTGCTCGTCCTCGCGGAGTGGCGGCGCTTCTACGACGACCCCGCCTGGTCCCCCGCCCCGCTCGACCACACCTTCCGCGACCACGTCCTCGCCGAGCGAGAGCTCCGCGACGGCCCGGCCGGCCGCCGCGCCGCCGACTACTGGACGGCGCGCCTCGACGAGATCCCCCCGGCGCCCGACCTGCCTCTGGCCACCGCCCCCGAGCAGATCGGCCCGCCCTCCTTCGTCCTGCACCGGGCCGTCCTGCCCCAGGACCGGTGGGCCGCCCTGTCGGCCACTGCCCGCCGGCACGGACTCACCCCCTCCAACCTGCTGCTCGCGGCCTACGCCGAGGTGCTGCGGACCTGGTCGCGGCGGCAGGAGTTCACCCTCACCCTCACTCTGTTCAAGCGGCTGCCGCTGCACCCGGAGACCAACGGCGTCGTGGGCAACTTCCTCTCCCCGAACCTGCTCACCGTCGACGGCCGATCCGACGAGACGTTCGGGCGCCGGGCTGCTCGGGTGCAGAACCGGCTGCTCGCCGACCTGGAGCACTCCGCGTACGGAGGAGTGCAAGTCCTGCGTGAACTGACCCGACGTCAGGGCGATGGGCGCAACGTGTCCATGCCGGTGGTCTTCACCAGCACCCTCGACGGCGACGAGGGCGACGCCAAGGGCGACCCGCTGAGCGTCTTCGGCGAACTGGCGCACAGCGCGAGCCAGACCCCCCAGGTCTGGCTGGAGAACCAGGTCTTCGAGGAGAACGGCGCCCTCACCGTCAACTGGAACGCGGTCGACGGGCTGTTCGCCCCCGACACGCTCGACGCCATGTTCCACGCCTACCTGGCCCTGCTGGACCGGCTCACCGACGACGAGAGCGCCTGGGAGACCGCCGGTGGCGCCGTACCCCTGCCCGCGGCCGAACTCGCCGAGCGCCGCGCGGCCAACGCGACCGCCACCGACATCCCGCCGCGGCGCCTCCACGAGCTGGTACACGAAGCCGCCCTCCGACGCCCCGACGCCGTCGCCGTGATCACCGACGGGACCGAGGTCACCTACCGGACGCTCCAGGAGAACGCGCACCGGATCGCCCGACGGCTCCGCGCGGAGGGCTGCGCGGAACCGGACACTCTCGTCGCCGTCTCCATGCGGCCGGGCGCCGCGCAGATCGCCGCCCTGCTGGGCGTTCTGCACGCGGGAGCCGCGTACGTCGCCATCGACCCGGAACTGCCCGAGGAGCGCCGCCACTCCCTGCTGCATCGATGTCGGGCCAGGGCCGTCGTCACCGAGGTGGAACTGGGCGCATCCCTCAGCTGGCCCGGCGGCATCCAGGTCGTCACCCCCGACGACCCGGCGACGCTGCGGTGCGGCACCGGACCGCTGGAGAGCCGGCAGAGCGTCGACGACCTCGCGTACGTGATCTTCACGTCCGGCTCCACGGGCGAACCGAAGGGGGTGATGATCTCGCACCGCAGCGCCGCGAACACCGTGCAGGACATCAACGCCCGCTTCGAGGTGAACGAGCGGGACCGGGTCCTGGCACTCGCCCCGGCCGGGTTCGACCTCTCCGTCTACGACGTCTTCGGGATCCTGGGCGCGGGCGGCTGCGTGGTTGTCCCCTCCGCCGGGCGCGGCAACGACGTCGCCCACTGGACGGAGCTGCTGGACCGGCACGGGGTCACCGTCTGGAACAGCGTGCCCGCCCCGATGCGTCTGTGGACCGAGTCCCTGGCCGACCTGGCCGAACAGGACGGCGCCGGGCACGGCGGGAGCCTGCGGCTGGCTCTGCTGAGCGGCGACTGGATCCCCGTCGCGCTGCCCGGCCAGATCCGTCGGCGCGTCCCGGGCATGCGGACGATCAGCCTGGGCGGGGCGACCGAGGGGTCGATCTGGTCGGTGTGCTACCCGATCGGGGAGGTTCCGGCCGACTGGACGAGCATTCCGTACGGCAAACCGCTCGCCAACCAGACCCTGCACGTCCTCAACACCTGGCTGGAACCGTCCCCGCGAGGAGTGACGGGCGACATCTACATCGGCGGCGTCGGCGTGGCCCAGGGCTACTGGAGCGACCCGGTACGCACGGCCGAGCGGTTCATCGAACACCCGGTGACCGGCGAACGGCTCTACCGGACCGGTGACCTCGGCCGGTACCTGCCCGGCGGGGACATCGAGATCCTCGGCCGTGAGGATTTCCAGGTGAAGATCAACGGCTATCGGGTCGAACTCGGCGAGATCGAGGCCGCTCTGGGCCGGCTGCCGGGCATGCGGCAGGTGATGGTCACCGCCCCGGCCCACCCCCGTACCGGACAGCGGCAGCTGACCGCCCACCTGGTCGGCGACGACCCGGCGGTCCTCGAACCGGTGGCCCTGCGCACCGCGATGGAGGCGGTGCTGCCCGGCTACATGGTGCCCTCGCACTATCTGACGCGAGACGCACTCCCGCTGACCGCGAACGGGAAGATCGACCGGGACGCGCTGGCGCTGCCCTGGAGCGACGGCGACGTGGCCCAGGGCCGGACCGCGCCGCGCGGCACCGTCGAGGAGCGACTGTTCGCGCTGTGGGCGGAGCTGCTGGGGCACAGCGAGTTCGGCGTCGAGGACGGCTTCTTCGACGTGGGCGGCGACTCGCTGCACGCCGTACGGATCATCGCCCGGCTGCGCGCCGACTTCGGCATCGACGAGAATGCCGAACAGCAGGTCATCGAGGGGCTGTTCATGAACGCGACGATCGCGGACTTCACCGAGGTCGTCCGGCCCTTCGAGGAGGCCGGCGCATGA	MEDLVAESLNSHPQTLPGAESRPAERHDAFPLTDIQHGYLIGRHKGLELGGVSSHYFFEFDGPALDVPRLTTALGRVVERHDMLRAVTDADGAQRVLAETPPYAIAVTDLREVSDAERDEALARIRAELENQVLPSDRWPPFDIRATHLPDRRTRLHVSVDLLFVDVRSLLLVLAEWRRFYDDPAWSPAPLDHTFRDHVLAERELRDGPAGRRAADYWTARLDEIPPAPDLPLATAPEQIGPPSFVLHRAVLPQDRWAALSATARRHGLTPSNLLLAAYAEVLRTWSRRQEFTLTLTLFKRLPLHPETNGVVGNFLSPNLLTVDGRSDETFGRRAARVQNRLLADLEHSAYGGVQVLRELTRRQGDGRNVSMPVVFTSTLDGDEGDAKGDPLSVFGELAHSASQTPQVWLENQVFEENGALTVNWNAVDGLFAPDTLDAMFHAYLALLDRLTDDESAWETAGGAVPLPAAELAERRAANATATDIPPRRLHELVHEAALRRPDAVAVITDGTEVTYRTLQENAHRIARRLRAEGCAEPDTLVAVSMRPGAAQIAALLGVLHAGAAYVAIDPELPEERRHSLLHRCRARAVVTEVELGASLSWPGGIQVVTPDDPATLRCGTGPLESRQSVDDLAYVIFTSGSTGEPKGVMISHRSAANTVQDINARFEVNERDRVLALAPAGFDLSVYDVFGILGAGGCVVVPSAGRGNDVAHWTELLDRHGVTVWNSVPAPMRLWTESLADLAEQDGAGHGGSLRLALLSGDWIPVALPGQIRRRVPGMRTISLGGATEGSIWSVCYPIGEVPADWTSIPYGKPLANQTLHVLNTWLEPSPRGVTGDIYIGGVGVAQGYWSDPVRTAERFIEHPVTGERLYRTGDLGRYLPGGDIEILGREDFQVKINGYRVELGEIEAALGRLPGMRQVMVTAPAHPRTGQRQLTAHLVGDDPAVLEPVALRTAMEAVLPGYMVPSHYLTRDALPLTANGKIDRDALALPWSDGDVAQGRTAPRGTVEERLFALWAELLGHSEFGVEDGFFDVGGDSLHAVRIIARLRADFGIDENAEQQVIEGLFMNATIADFTEVVRPFEEAGA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	195.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0000373.1|Holomycin_7 # 8836 # 9441 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000373.1|Holomycin_7 	8836	9441	+	Loose	750	24.6386	smeA	33.33	3003051	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAAATCCGATCCCCTCTCCTTCCGGAGGAAAACGCATACTCGTCGCCGCCACCGGTTCCATTGCGACGCCGTCGCTGCCGTCGTATCTCGGCACCCTGCGGGCACGTCTGGACGTCACCTGCACCGTGCTGCTCACGCCGGCCGCCACTTCGTTCCTGTCGCCGCAGACGGCGGCGCTTTTCGCGGAGCGGGTGGTCAGCGGCGAGTCGCCGGACGACTGGCCGACCGACAAACCGTCCCGGCTGGCGGCCGACCACGACATCCTGCTGGTGCTGCCGGCGACGGCGAACACGCTTGCCATGGCCGCCACGGGGGCCGCCCCCAACCGCCTCGGCACAGTGATCCTCGCTGCGGACTCCCCCGTGGCGTTCTTCCCGGTCATGGGCGCGCGCATGTGGGAGAAGCCGACTGTGCGGCGCAATGTCGCGCAGCTGCGGGAGGACGGCTGTGTGGTGCCGGAGCCCGTCTGGCACGAGGGTTTCGACCCCGGAACGGGCAACCGCTCCAGCCATCCGTCGCTGCCCTCGCCCGAGCAGGTGGCCAAGCTCGTCGCCGAACTGCTGGCCACATCGGAGAACCACCGACGAACGGAGGTGTCGTGA	MENPIPSPSGGKRILVAATGSIATPSLPSYLGTLRARLDVTCTVLLTPAATSFLSPQTAALFAERVVSGESPDDWPTDKPSRLAADHDILLVLPATANTLAMAATGAAPNRLGTVILAADSPVAFFPVMGARMWEKPTVRRNVAQLREDGCVVPEPVWHEGFDPGTGNRSSHPSLPSPEQVAKLVAELLATSENHRRTEVS	MSLLRPLSRSPRPLLLPLLLALAACSADRTDAPAMPEVGVIIASAQPLALQQTLPGRAVPFEISEVRPQIGGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSAQPKAERTRALVSMDAASKQDADDATSALKQAQANVIAARAALQAARINLDYTRVTAPIDGRIGTSSVTAGALVAAGQDTALTTIQRLDPVYLDVTQSSTQMLALRKRLDAGLVKAIDGKAQVKVLLEDGSTYAHEGTLEFVGSAVDPGTGNVKLRAVIPNPDGLLLPGMYLKAVLPMATDARALLVPQKAVVRNERGEPLLRLLDAKDHVVERRVSTGQVVGNQWQITSGLKAGERVIVSNGSAVSLGQQVKAVAPTTAQLAAMPAVDPNGNTDEKSH	50.50	gnl|BL_ORD_ID|1388|hsp_num:0	1507			714	846	
BGC0000373.1|Holomycin_8 # 9441 # 9905 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.660	BGC0000373.1|Holomycin_8 	9441	9905	+	Loose	500	26.5646	PER-10	29.69	3006131	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGGCGGAGGACATTCCGACGATGTACGAATGGGTCGGTGGCGCAAAAACGCTGGAACGGCTCACCGAAGAGTTCTACCGGCGAGTACGCAAGGATGAACTCCTGGCCCCGCTCTTCCAGTACATGACGGATGACCACCCTCAGCACGTGGCGACCTGGCTCGGCGAGGTCTTCGGGGGGCCCGCGACCTACACCGAAGAACTCGGCGGGTTCCGGCGCATGCTGAAGAGCCATCGTGGCCGGGCTATCCAGCCGGAACAGCGGCAGCGCTGGGTGACGTTGATGCTGGAGGCCGCCGACGAAGTCGGACTGCCTTCCGACTCGGAGTTCAGGTCGGCATTCGTCGCGTATATCGAATGGGGTTCCCGCCGGGCCATGGCGAATTCCCAGCCCGACGCGCAGCCCTCGCGGCGGGAGACCGTTCCGGTCTGGGGCTGGGGCGAGTCCCCGCCCGGCAAGGCCTGA	MAEDIPTMYEWVGGAKTLERLTEEFYRRVRKDELLAPLFQYMTDDHPQHVATWLGEVFGGPATYTEELGGFRRMLKSHRGRAIQPEQRQRWVTLMLEAADEVGLPSDSEFRSAFVAYIEWGSRRAMANSQPDAQPSRRETVPVWGWGESPPGKA	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSDSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN	50.00	gnl|BL_ORD_ID|4543|hsp_num:0	5613			291	483	
BGC0000373.1|Holomycin_9 # 9975 # 11447 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.738	BGC0000373.1|Holomycin_9 	9975	11447	-	Loose	1000	117.857	efpA	32.6	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGACCCCACCAAGCCGCTGACCGAACCCAAGCTGCCCCCGAGAACACCGGCGGCCGGACCGGTGGGCTCCGGCGACGGCCCCGGGGGTGGGCACCGAGCCCCCGGCAAGGACACCGGGTCCCCGGCCGGGCTGGCGTTCGTGATGCTCGCCGTCGTCCAGGCCACGCTGATCTTCACCATCACCCTGATCGCGGTGCCGCTGCCCGCGATCGGCCGGGAATTCGGCCTGAGCGCCGCGGACCTGGTCCTGGTCAACGCGGCGTACGGGCTTCCCTACAGCGGTCTGCTGCTGTTCGGCGGCCGGCTCGCCGACCGGTACGGCGGCCGCCCGATGTTCGTGCTGGGCCTCGTGCTGTTCGGCCTCGCGTCCGCGGCGGCGGCCTGGGCCCCCTCATTCGAGGCGCTGGTCGCCGTACGGTTCAGTCAGGGCCTGGGCGCGGCGCTCACCGCACCGGCGGCGCTCGCCGTACTGCGCGCCGTCTTCCGCGAGCCCGCGGCCTTCGGCCGGGCCATGGCGAGCTGGGGCGGTGTGTCCGTCCTCGGCGCCGCGGTCGGCACGCTGACTTCGGGCGCCGTCACCACCTGGGTCTCCTGGCGCTGGATGTTCGCTGTTCCCGTGCTCGTCGCCGCGATCGCGCTTCTGCTGACCCGCCGGCTGCTCCCGGCCGACCCCGCCGACGCCTCGGCCGCCCCGCAGGGTCTCGACCCGGCAGGGGCACTCCTCGCCACCCTGGGTATCTCGATCGGCAGCTACGGCCTCATCCTCAGCGGTGAGCACCCGTGGAGCTCGCCCCACGTCCTCGTACCCCTCGCGATCGGGGCCGTCCTGCTTGTCCTGTTCCTGATGGTCGAACGGCACGTACGGGATCCGCTCCTGCCGCCCGGCTTCACCATGGAGCCCCGTCGGCTGGTGGGCCTCGTCGGTATCCTGCTGGCAGCGGCGGGCACCGGCCTGGTGACCTTCCTGCTCTCCCTCTACCTCCAGCAGCAGCAGGACTGGTCCACCCTGGCCACGACCGGCGCGTTCGTTCCCTTCACCCTGGCCCTGATCATCGCCAACCAGCTGGCCGGGCGGGCGGTCGGCCGGTACGGCCCGGGAGCCGTCACCATCGCCGGGCTGGTGGCCGGCGCCGTCGGGCTGGCGCTGCTCACCGGCATCGGCCCCGGCACTTCCTTCGCCCTCGGGCTGATGCCGGGCGCGGTTCTGCTGGCGGCGGGCACGTCCTTCATCTTCTCCGGCTCCGCCGTGCTGACCACCACGAACGTCCCCGCCCACCAGGCCGGACTGGCGGGCGGGGTGATGAACACCGCTATGGAACTGGGGCCCACGGTGGGCCTGGCCGCTCTGATGGCGGTGGCCGCGGCCCAGGCCGATGTGGTCGTCGGCTACGCCTGGGCGTTCGGCGCCGGAGCCGTTGTCTACCTGGTCGCCGCGCTCGCGGGGGCCGCGGTGGTGCGGCGCCCGGACTAG	MDPTKPLTEPKLPPRTPAAGPVGSGDGPGGGHRAPGKDTGSPAGLAFVMLAVVQATLIFTITLIAVPLPAIGREFGLSAADLVLVNAAYGLPYSGLLLFGGRLADRYGGRPMFVLGLVLFGLASAAAAWAPSFEALVAVRFSQGLGAALTAPAALAVLRAVFREPAAFGRAMASWGGVSVLGAAVGTLTSGAVTTWVSWRWMFAVPVLVAAIALLLTRRLLPADPADASAAPQGLDPAGALLATLGISIGSYGLILSGEHPWSSPHVLVPLAIGAVLLVLFLMVERHVRDPLLPPGFTMEPRRLVGLVGILLAAAGTGLVTFLLSLYLQQQQDWSTLATTGAFVPFTLALIIANQLAGRAVGRYGPGAVTIAGLVAGAVGLALLTGIGPGTSFALGLMPGAVLLAAGTSFIFSGSAVLTTTNVPAHQAGLAGGVMNTAMELGPTVGLAALMAVAAAQADVVVGYAWAFGAGAVVYLVAALAGAAVVRRPD	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	92.45	gnl|BL_ORD_ID|2188|hsp_num:0	2427			192	1128	rifampin; isoniazid
BGC0000373.1|Holomycin_11 # 12619 # 13218 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000373.1|Holomycin_11 	12619	13218	+	Loose	100	28.1054	vanU gene in vanG cluster	30.65	3004253	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanU	ATGAAGCAATCACCTGCCATCTCCCAGGTCCTCGACGAGGTGGGCCCCCGGTTGCGCTGGCTGCGCACGCAGCGCGGGGTGTCGCTGACCGCGATCGCCGAGGCGACCGGAATCTCCAAGAGCACGCTGTCCCGGCTGGAGTCGGGTCAGCGCCGGCCGAGCCTGGAGCTGTTGCTGCCGATCGCCCAGGCCCACCAGGTCCCCTTGGACGAGCTGGTGGGCGCTCCGGAGGTCGGCGATCCGCGAATCAGGACCTCGCCCCGGAGCGTCAACGGCAACACGGTGCTGCCGCTGACCCGCCAGCCCGGTCCACTCCAGGCGTTCAAGATGGTGCTGCCCGCCACCCGGAAGACGCCCGACCTGTGCAACCACGAGGGATACGAGTGGCTGTACGTCCTCTCCGGCACGCTCCGGCTGCTGCTGGCCGACCACGATCTGACGCTGGGTCCGGGTGAGGCGGCCGAGTTCGACACCCGGCTGCCGCACTGGTTCGGCACCACCGGGGAGGGACCCGTCGAGGTGCTCAGCCTCTTCGGCCGGCAAGGGGAGCGTATGCACGTACGGGCCCGCCCCCGGGACGGAAGCCACCCGTCCCGTTGA	MKQSPAISQVLDEVGPRLRWLRTQRGVSLTAIAEATGISKSTLSRLESGQRRPSLELLLPIAQAHQVPLDELVGAPEVGDPRIRTSPRSVNGNTVLPLTRQPGPLQAFKMVLPATRKTPDLCNHEGYEWLYVLSGTLRLLLADHDLTLGPGEAAEFDTRLPHWFGTTGEGPVEVLSLFGRQGERMHVRARPRDGSHPSR	MRVSYNKLWKLLIDRDMKKGELREAVGVSKSTFAKLGKNENVSLTVLLAICEYLNCDFGDIIEALPETPDKERDS	265.33	gnl|BL_ORD_ID|4736|hsp_num:0	943			30	213	vancomycin
BGC0000373.1|Holomycin_13 # 13912 # 15225 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.753	BGC0000373.1|Holomycin_13 	13912	15225	-	Loose	700	31.5722	CMA-1	34.67	3006922	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CMA beta-lactamase	ATGTCCACGAAGACCGAAGAGCCAGGCACGGAACACCTTTCCCCCTTCCAGGCCGGGCTGCTCGCGCAAGTGCGTCGGCGGCCCGGCACCGGGGTGTGCGTCGATCACGTGGTGATCGGCCTCACCGGCACTCTCCATCCGTACGTGCTCGCCGAGGCATGGCGGGAGCTGGCGTGCCGTCCTTCCGCGCTGCGCGCCGGGGTACGGGACCACGCGGACGGCTCCGCCGCCTACCGGTCGGATGGTCGGCCGGTGTGGCGGGCGGTGGACTGGAGAGCCACCCGGGAGCCTGTACGGGGGGCCATGCTGCGCGAGCGGCTGGACCGCGAACGGGCCCACGGACTCCCGCTGGATGGCACCCCGTTGAGCCGGACCCTGCTGGTGCGGTGCGGCGAACAGGAGTGGACCCCTGCCTGGCGCTTCTCCCGCCCGGTGGTCGACCAGTGGTCGGCCGCCACTGTCGTCACCGAACTGTTCGCAGCCTACCGGGCGTTGCTCGCGGGCCGATGTCCGAAGCCGGCGACGGCACCCCGATACCCGGACGGACTGACCGCCCGGCCCGTCCCGGCCAGAACCCCGAGGTCCCGAGCCGGGAGCACGCCTGTTCCGGACCCCGACCTGTCGGCGCGGGCCCTCGTGCCGGCACGGCACTTCCTGCTGATGCCGGACGACGAGCGGCCACCCCACCACGCCACCCCCTTCGACGCCGTGGATCTGGACCTGGGCGCTTCGGCCGCCGCCGTACGCCGCATGTGCCGGACACACGGGATCGTCCCCGCCGCCGTGCTGCACGCCGCCTGGCTGATGCTGCGGCCCACCGGAGCCGGAGGCCGCCCGGCCTGGGAGGCCGTCCTCCCGCGACGGCCCGTCGGACGGCCGGGGACCTGGGACGCCGTCGGATCGAGGGAGACCGCGGTGACGCTCCCGGCCGTACCGGACATGCCCCGGCCCCTGCTGTCCTGGCTGGACGAAATCGGCGGCCGGCTGACGGACGCCGTCGGGTCGGACCACGGCGTCCCCGGGTCAGGGACCGCGGACAGCGCCGTATTCGCCGGTGAGGCGGAGCTGCCCCGCCCCGACCTGCTCGACCTGGGCCTCAAGGTCACCGCCGCGCACGACGACGCCCGCCCGCACCACGCCCTGGCCCTGCGCCTCCGGCCCGGACAGGACCTGCCGGTGCGCCTCACCTACGACCGGACCCGCACCTCCCGCTCCACGGCCGAGCGGCTCACGGCCCAGCTGCGGGACCTGGTGGGCGCCCTCGCCGGCGCGTCCCCCCGGACCACCGTGGCCGAACTCGGGGCGGGCGCGTGA	MSTKTEEPGTEHLSPFQAGLLAQVRRRPGTGVCVDHVVIGLTGTLHPYVLAEAWRELACRPSALRAGVRDHADGSAAYRSDGRPVWRAVDWRATREPVRGAMLRERLDRERAHGLPLDGTPLSRTLLVRCGEQEWTPAWRFSRPVVDQWSAATVVTELFAAYRALLAGRCPKPATAPRYPDGLTARPVPARTPRSRAGSTPVPDPDLSARALVPARHFLLMPDDERPPHHATPFDAVDLDLGASAAAVRRMCRTHGIVPAAVLHAAWLMLRPTGAGGRPAWEAVLPRRPVGRPGTWDAVGSRETAVTLPAVPDMPRPLLSWLDEIGGRLTDAVGSDHGVPGSGTADSAVFAGEAELPRPDLLDLGLKVTAAHDDARPHHALALRLRPGQDLPVRLTYDRTRTSRSTAERLTAQLRDLVGALAGASPRTTVAELGAGA	MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVASKATRKPVDEKTLFEIGSLSKTFTATLASGAQHEGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTAGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLKGFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPNDDRVKAAYAIIQQLDK	116.53	gnl|BL_ORD_ID|3392|hsp_num:0	4461			618	786	
BGC0000373.1|Holomycin_14 # 15523 # 18318 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000373.1|Holomycin_14 	15523	18318	+	Loose	1000	30.4166	MCR-1.29	25.98	3007241	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGTCAAGGGAGTTGTTCGGACGGAATAAGGAATTCCGGATCATCGAGGAGATGCTCGACTCCGCGTTGGCGGGCGAAGGAGCCTCCGCCCTGATGGAGGGCATCATCGGGACCGGGAAGACCACGCTGCTCCGATGGTCGGAGGAGCAGGCCCGGCAGCGGGGCATGCTGGTGCTTTCAGCCACCGCCGCCCCTACGGAACGCCGCTTTTCGATGGGTATCGTTCATCAGCTGTTCAGCTGTCTGGAAAATGCGGGAGTCCCCTCGGCCCCACCCGGACAGGGCGCGCCGCATCCGGCACCGGTCGACCCGCAATATCTGCATCTCTCCGATCTGTACAAGGTAATAAGTGCGACATCGGAGCGCATCCCGATTCTGGTGACGATCGATTGCATTCAGTGCGTCGATCGGGATTCTCTCTTATGGCTGGGATTCCTCTTGCGTCGGATCGAAAACATTCGGGTGGTGTTGCTGGCGAGCCGGCGCCGGGGAGAACCAGCCAGCGACCAGCACCTTCTGGTCGAATTCATGGAGAGCATCCGTCCGGATCGGCATCTGCATCTGGAGGACCTCAGCCCGAGTACCGCGTCCCGTCTGGTCGAGGCCCTCGGCAGCTGCGTCCCGGGTCCCGCGGAGACTCTCATCGCGGACAGCGGCGGCAATCCGTATCTGCTGACCCAGCAGATACTGGCCACCCCCAGCGCGGAGCAGTCGGGCGACGGAGATCGGCGCGACTCCGCGGCGGACCTCCCGATAAGACTCCGGGCGGTCAAGGACCGCGTGTTGTGCCTGCTGCGCCGACTGGACCTCGACGGTCTGCGCGTCGCGCACGCCGCCAGCGTCGTCGGCGGCTCGGCGATGAACGCCGAACTCATCGGAGAACTCTGTTCCTTGTCCGTGGAGGATGCGTCACGCAGCCTGGAGCAGCTGGCCGAGTGCGGCATCCTGCACCCGACGAGCCTGACATTCCGCCACCCCATCATCGCGCGGCTCCTCTACCTCGACATCCCGCGCTCGCACCGTGCCGTGCTGCACCAGCAGACCGCCCGGTGTCTGCACAACCGCAGGTTCGCCCCCGCCGACATCACCCCGCACCTCGTGCAGGCGGCCACCCTGGACGAACCGTGGATGGCCACCCTGCTGCTGGACGCGGCGGAGGAGCTGCTGCCGGGGGACGCGCCCACGGCTCTCCAGCACATCGAGACAGTGGAGCGTCACGGCGTCCCGGAGCAGCTGGCCTTGCGCATCGCCGAACTGCGGGTGCGAACCCTCCTCGAACTGGACCTCCCCGGATCCGTACCGGCGCAGTACGCGCTGCTCGGGCTCAGTTCGGGGCACCGGGAGCTGGCCGCGCGTGCGCACCGGCTGGCCGACACCCTGATCCGCCTCGGCAGGCCGCAGGAGGCCCGTCAGGTGCTCAACGGCGCCCAGTCGGTGCGGGACAAGGGCACGGCCGCGGCGGCCCGGCTGAGCCGGCACCTGGCCCACATCTGTATGGACGACGGCGCGTGCGCCGGCGCCCCGCGCGGGCTTGAGCGTCTGGAGAGCGTCATGCTGCGCCGTATCGGGAACGGCGAGTCGGCCTCCGCCGCGCGCCGGCTCTGCCGCATGTGCCTCGCCACGCCCCGCACCCCCTACGGTTCGCCTTCCTGGTACTACGCGCTGCTGGGGCTGATCTGGGCGGGGGACTTCGACGAGGCGCAGAGTCACATCGACACGGAGGTGCGGCTCGCGGTCCAGGAGGGCGCGGCGACCCGCATCGCCGAAGCCCGGTCCGTCCGCGCCCTGCTGCACATGCACCGGGGCCTGCTCACGGAGGCGGGGCACGACGCCCGGCTGGCACTCACCGCACTGCGGCGGATCGGCGCGGACGCCCATCACATGGGCGCCCTGGCCCGCAGCGTGCTGATCGATGTGGCCGTGGAGAAGGACCAGCTCGCCGAGGCGAGCGAACTGCTGGACGTCCAGGTGCCGCCGGCCGGGCAGCCCGCCGCCTGGTGGCATCTGCACCTCGCCCACAGCGCCGCCCGCGCTCTGGGCCGGTTGGGTCACACGCGACAGGCCCTGGCTCTCGTCACCTACTGCGAGCGGGAGCTGGGCCGCCGGGGGATCAGCAACCCGGCGGTGCTGCCGTGGCGTTCGACCAAGGCGCTGATCTGTGCCGGTCTGGGCAATCTGCCCGACGCCCGGCGGCTGGCCCAGCAGGAGGCCGACCTCGCCCTGCGCTGGGGCGCACCGTTCGCCCAGGGCAGGGCGCTGCTCGCGCTGGCCGCCGTGTCTCCCGTGGGTGACGTGCTGCGGCTCACCCGTCGCGCGGTCGACCTCCTCGACGCGGAGGAGGCTCCGTTGCTGTACGCGCAGTCGCTGTACGCGACGGGGCACGCCTATCAGCAGGACGGATCCACCGTCCGAGCCCGCGAGTTGCTGCACCGGGCCAACGAGGTGAGCATCGCTCTGGGCGCGGACGGACTGGTGGAGCTGGTGCAGAAGGCGCTGCGTGACGCGGGCGGCCGGCCGGACCCCCGCAAGGTGTCCGCGGAGGCGCTGTTGACGCCTTCGGAGCGTCAGGTCGCCAAGCTGGCCTCGCAGGGTATGAGCAATCGGGACATCGCCCGGTTGCTCCACGTGAGCCTGCGCAACGTCGAATCGCATCTCACACACTGCTACCGCAAGCTCCGGATCAGCGGCCGGGGCGAGCTGAGCCGGTTCCTGCCGGCCGATGACGGCGAGGCGGGCCCAACGCTCCTGCATCCTCACGCCGCCGCGGGCTACCACCGCCACCGGCAGTCCGCCTGA	MSRELFGRNKEFRIIEEMLDSALAGEGASALMEGIIGTGKTTLLRWSEEQARQRGMLVLSATAAPTERRFSMGIVHQLFSCLENAGVPSAPPGQGAPHPAPVDPQYLHLSDLYKVISATSERIPILVTIDCIQCVDRDSLLWLGFLLRRIENIRVVLLASRRRGEPASDQHLLVEFMESIRPDRHLHLEDLSPSTASRLVEALGSCVPGPAETLIADSGGNPYLLTQQILATPSAEQSGDGDRRDSAADLPIRLRAVKDRVLCLLRRLDLDGLRVAHAASVVGGSAMNAELIGELCSLSVEDASRSLEQLAECGILHPTSLTFRHPIIARLLYLDIPRSHRAVLHQQTARCLHNRRFAPADITPHLVQAATLDEPWMATLLLDAAEELLPGDAPTALQHIETVERHGVPEQLALRIAELRVRTLLELDLPGSVPAQYALLGLSSGHRELAARAHRLADTLIRLGRPQEARQVLNGAQSVRDKGTAAAARLSRHLAHICMDDGACAGAPRGLERLESVMLRRIGNGESASAARRLCRMCLATPRTPYGSPSWYYALLGLIWAGDFDEAQSHIDTEVRLAVQEGAATRIAEARSVRALLHMHRGLLTEAGHDARLALTALRRIGADAHHMGALARSVLIDVAVEKDQLAEASELLDVQVPPAGQPAAWWHLHLAHSAARALGRLGHTRQALALVTYCERELGRRGISNPAVLPWRSTKALICAGLGNLPDARRLAQQEADLALRWGAPFAQGRALLALAAVSPVGDVLRLTRRAVDLLDAEEAPLLYAQSLYATGHAYQQDGSTVRARELLHRANEVSIALGADGLVELVQKALRDAGGRPDPRKVSAEALLTPSERQVAKLASQGMSNRDIARLLHVSLRNVESHLTHCYRKLRISGRGELSRFLPADDGEAGPTLLHPHAAAGYHRHRQSA	MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGSAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	172.09	gnl|BL_ORD_ID|4861|hsp_num:0	5846			861	1236	colistin A; colistin B
